InNexus Biotechnology Announces Oversubscription of Private Placement Raised to $5 Million and Additional Equity Financing up to $7.5 Million
In: Business Wire, 2008-05-30
Zeitungsartikel
Zugriff:
BRITISH COLUMBIA, Canada -- InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS) (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its technology, Dynamic Cross Linking (DXL™), [...]
Titel: |
InNexus Biotechnology Announces Oversubscription of Private Placement Raised to $5 Million and Additional Equity Financing up to $7.5 Million
|
---|---|
Zeitschrift: | Business Wire, 2008-05-30 |
Veröffentlichung: | 2008 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|